Tulathromycin: Long-Acting Veterinary Macrolide Antibiotic
Tulathromycin is a semi-synthetic triamilide macrolide antibiotic designed specifically for veterinary use. It achieves exceptionally high and sustained concentrations in pulmonary tissue and alveolar macrophages due to extensive distribution and ion trapping in acidic intracellular compartments. This results in effective antimicrobial activity at the site of respiratory infection with a single injection.
Product Profile
| CAS Number | 217500-96-4 |
|---|---|
| Molecular Formula | C41H79N3O12 |
| Appearance | Clear to slightly opalescent solution (as formulated); pale solid as raw material |
| Therapeutic Category | Veterinary Macrolide Antibiotic |
| Storage | Store at controlled room temperature |
Applications
Tulathromycin is indicated for the treatment and prevention of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in cattle. It is also approved for swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs. A single subcutaneous injection at 2.5 mg/kg provides therapeutic concentrations in the lungs for up to 15 days. Its one-dose protocol improves compliance and reduces animal handling stress in feedlot and swine production settings.
Why Source from TCS
TCS supplies tulathromycin to veterinary pharmaceutical companies across Europe and globally. Flexible order quantities from development samples to commercial volumes. Contact us with your target market and project requirements for a tailored quotation.
FAQ
What information should be included in an inquiry for Tulathromycin 217500-96-4?
A useful inquiry normally includes the product name, target application, estimated quantity, destination market, and any specific documentation or packaging requests.
How is Tulathromycin 217500-96-4 usually evaluated for sourcing?
This product is positioned for pharmaceutical sourcing discussions covering development, pilot, or commercial demand, subject to the buyer confirming application scope, market, and document requirements.
What documentation and commercial points are commonly reviewed before buying Tulathromycin 217500-96-4?
For pharmaceutical API procurement, buyers commonly align on specification review, target market, batch or annual demand, packaging expectations, and the documentation package needed for the project.
Request a Quote
If your team already has a target application, estimated quantity, destination market, or documentation requirements, send those details so the commercial response can be prepared more efficiently.